Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIBOFLAVIN 5'-PHOSPHATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIBOFLAVIN 5'-PHOSPHATE: Safety Overview

Metric REZAFUNGIN RIBOFLAVIN 5'-PHOSPHATE
Total FAERS Reports 108 249
Deaths Reported 12 0
Death Rate 11.1% N/A
Hospitalizations 20 3
Average Patient Age 53.8 yrs 31.1 yrs
% Female Patients 54.3% 31.4%
FDA Approval Date Mar 22, 2023 Apr 15, 2016
Manufacturer Melinta Therapeutics, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription